For research use only. Not for therapeutic Use.
VU0364770 hydrochloride is a selective and potent positive allosteric modulator (PAM) of mGlu4. VU0346770 hydrochloride exhibits EC50s of 290 nM and 1.1 μM at rat mGlu4 and human mGlu4 receptor, respectively. VU0364770 hydrochloride exhibits antagonist activity at mGlu5 with a potency of 17.9 μM and PAM activity at mGlu6 with a potency of 6.8 μM. VU0364770 hydrochloride also possesses activity at MAO with Ki values of 8.5 and 0.72 μM for human MAO-A and human MAO-B, respectively[1].
Catalog Number | I018001 |
CAS Number | 1414842-70-8 |
Synonyms | N-(3-chlorophenyl)pyridine-2-carboxamide;hydrochloride |
Molecular Formula | C12H10Cl2N2O |
Purity | ≥95% |
InChI | InChI=1S/C12H9ClN2O.ClH/c13-9-4-3-5-10(8-9)15-12(16)11-6-1-2-7-14-11;/h1-8H,(H,15,16);1H |
InChIKey | CZNNJOSFWZBQKH-UHFFFAOYSA-N |
SMILES | C1=CC=NC(=C1)C(=O)NC2=CC(=CC=C2)Cl.Cl |
Reference | [1]. Jones CK, et al. The metabotropic glutamate receptor 4-positive allosteric modulator VU0364770 produces efficacy alone and in combination with L-DOPA or an adenosine 2A antagonist in preclinical rodent models of Parkinson’s disease. J Pharmacol Exp Ther. |